Allergan Bid Nears $53 Billion

Valeant Pharmaceuticals boosted its takeover bid for Botox-maker Allergan for the second time this week, offering about $52.7 billion in cash and stock.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news